Ignite Creation Date:
2024-05-06 @ 6:03 PM
Last Modification Date:
2024-10-26 @ 2:40 PM
Study NCT ID:
NCT05523869
Status:
RECRUITING
Last Update Posted:
2023-03-02
First Post:
2022-08-29
Brief Title:
Intravitreal Topotecan in the Repair of Rhegmatogenous Retinal Detachment With Proliferative Vitreoretinopathy
Sponsor:
Unity Health Toronto
Organization:
Unity Health Toronto
Organization Data
Organization:
Unity Health Toronto
Class:
OTHER
Study ID:
TOPO-RD
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Unity Health Toronto
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None